Linear Capital Named Among Zero2IPO China's Top 10 Early-Stage Investment Firms | Linear News
Continued focus on early-stage investments in frontier technology.
Today, Zero2IPO Research released its annual China equity investment rankings for the 25th consecutive year, using a professional, scientific, and quantifiable methodology to analyze and screen data across fundraising, investment, and exit activity.
Linear Capital was once again named to the "Top 30 Early-Stage Investment Firms in China" at #9, and Harry Wang, Founder and CEO of Linear Capital, was named to the "Top 10 Early-Stage Investors in China."
On December 29, Zero2IPO Research, a subsidiary of Zero2IPO Group, officially released the annual China equity investment rankings — the 25th consecutive year since 2001 that Zero2IPO has published these rankings.
Zero2IPO Research relies on its professional SaaS system for the private equity investment sector, PEdata, to conduct multi-angle analysis and screening in a professional, scientific, and quantifiable manner. Based on detailed data, real market conditions, and scientific standards, it selected the 2025 awards across four major categories: VC/PE comprehensive rankings, sector-specific rankings, outstanding case awards, and intermediary institutions — totaling dozens of lists — with the aim of comprehensively and accurately reflecting market development and competitive dynamics.
Among the results, Linear Capital was ranked #9 on the 2025 "Top 30 Early-Stage Investment Firms in China", and Harry Wang, Founder and CEO of Linear Capital, was named to the "Top 10 Early-Stage Investors in China."
